Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1969 3
1970 7
1971 5
1972 9
1973 5
1974 2
1975 3
1976 2
1977 4
1978 1
1979 3
1980 4
1981 1
1982 1
1983 3
1984 2
1985 3
1986 1
1987 1
1988 11
1989 9
1990 7
1991 8
1992 3
1993 15
1994 4
1995 5
1996 2
1997 2
1998 4
1999 9
2000 3
2001 3
2002 9
2003 9
2004 11
2005 8
2006 8
2007 3
2008 8
2009 7
2010 3
2011 2
2012 3
2013 3
2015 1
2016 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Results by year

Filters applied: . Clear all
Page 1
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
ADVANCE Collaborative Group; Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. ADVANCE Collaborative Group, et al. N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6. N Engl J Med. 2008. PMID: 18539916 Free article. Clinical Trial.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators. Baigent C, et al. Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12. Lancet. 2011. PMID: 21663949 Free PMC article. Clinical Trial.
The MPO Study: just a European HEMO Study or something very different?
Locatelli F, Gauly A, Czekalski S, Hannedouche T, Jacobson SH, Loureiro A, Martin-Malo A, Papadimitriou M, Passlick-Deetjen J, Ronco C, Vanholder R, Wizemann V; Membrane Permeability Outcome (MPO) Study Group. Locatelli F, et al. Among authors: czekalski s. Blood Purif. 2008;26(1):100-4. doi: 10.1159/000110574. Epub 2008 Jan 10. Blood Purif. 2008. PMID: 18182806 Review.
[Treatment of osteoporosis].
Miazgowski T, Czekalski S. Miazgowski T, et al. Among authors: czekalski s. Pol Tyg Lek. 1993 Nov;48 Suppl 3:50-3. Pol Tyg Lek. 1993. PMID: 8309840 Review. Polish. No abstract available.
221 results